Palatin Technologies
PTN
#9982
Rank
A$50.25 M
Marketcap
A$29.51
Share price
23.93%
Change (1 day)
1,290.70%
Change (1 year)

P/E ratio for Palatin Technologies (PTN)

P/E ratio as of January 2026 (TTM): -0.6652

According to Palatin Technologies's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.665217. At the end of 2022 the company had a P/E ratio of -0.0186.

P/E ratio history for Palatin Technologies from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
2022-0.0186-73.28%
2021-0.0697-43.65%
2020-0.1236
2014-1.46

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
MediciNova
MNOV
-5.52 729.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-0.3019-54.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
31.6-4,843.14%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
46.0-7,015.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
80.3-12,178.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
19.6-3,042.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-26.5 3,880.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
30.1-4,618.22%๐Ÿ‡ฌ๐Ÿ‡ง UK

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.